Company Description
China Jo-Jo Drugstores, Inc., together with its subsidiaries, operates as a retailer and distributor of pharmaceutical and other healthcare products in the People's Republic of China.
The company operates through four segments: Retail Drugstores, Online Pharmacy, Drug Wholesale, and Herb Farming.
Its stores provide various pharmaceutical products, including prescription and over-the-counter drugs, nutritional supplements, traditional Chinese medicines (TCM), personal and family care products, and medical devices, as well as convenience products, such as consumable, seasonal, and promotional items.
The company also operates licensed doctors of Western medicine and TCM on site for consultation, examination, and treatment of common ailments at scheduled hours.
In addition, it operates online drugstore that retails OTC drugs and nutritional supplements, as well as sells products through third-party platforms.
Further, the company distributes third-party pharmaceutical products primarily to trading companies, as well as cultivates and wholesales herbs used for TCM.
It operates retail pharmacies under the Jiuzhou Grand Pharmacy name. The company was founded in 2003 and is headquartered in Hangzhou, the People's Republic of China.
| Country | China |
| Founded | 2003 |
| Industry | Pharmaceutical Retailers |
| Sector | Healthcare |
| Employees | 885 |
| CEO | Lei Liu |
Contact Details
Address: Hai Wai Hai Tongxin Mansion Floor 6, Gong Shu District, Hangzhou Zhejiang Province, F4 310008 China | |
| Phone | (86) 1501-158-6601 |
| Website | jiuzhou-drugstore.com |
Stock Details
| Ticker Symbol | CJJD |
| Exchange | NASDAQ |
| Fiscal Year | April - March |
| Reporting Currency | USD |
| CIK Code | 0001413263 |
| CUSIP Number | 16949A206 |
| ISIN Number | KYG2124G1120 |
| Employer ID | 98-0557582 |
| SIC Code | 5912 |
Key Executives
| Name | Position |
|---|---|
| Lei Liu | Chairman and Chief Executive Officer |
| Ming Zhao | Chief Financial Officer |
| Steve Liu | Investor Relations Director |
| Yan Liu | Secretary |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jul 30, 2021 | 15-12B | Securities registration termination |
| Jul 29, 2021 | 25-NSE | Filing |
| Jul 28, 2021 | 8-K | Current Report |
| Jul 20, 2021 | 8-K | Current Report |
| Jul 1, 2021 | 8-K | Current Report |
| Jun 29, 2021 | 10-K | Annual Report |
| Jun 2, 2021 | DEF 14A | Other definitive proxy statements |
| May 14, 2021 | 8-K | Current Report |
| Apr 22, 2021 | 8-K | Current Report |
| Feb 12, 2021 | 8-K | Current Report |